Home > Monitoring new drugs.

European Monitoring Centre for Drugs and Drug Addiction. (2006) Monitoring new drugs. Luxembourg: Office for Official Publications of the European Communities.

[img]
Preview
PDF (Monitoring new drugs) - Published Version
55kB

The Lisbon-based European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the central source of comprehensive information on drugs in Europe. Its main task is to collect and disseminate data on the use of substances controlled by the United Nations drug conventions (1). However, in recent years, the Centre has become increasingly active in monitoring new substances not listed in these conventions, but which may pose health and social risks to our societies. Today this activity is carried out under the terms of a specific legal instrument adopted by the Council of the European Union in 2005.

Date:2006
Pages:2 p.
Publisher:Office for Official Publications of the European Communities
Corporate Creators:European Monitoring Centre for Drugs and Drug Addiction
Place of Publication:Luxembourg
EndNote:View
Accession Number:HRB (Electronic Only)
Subjects:B Drugs and alcohol substances > New (novel) psychoactive substances
VA Geographic area > Europe

Repository Staff Only: item control page